Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hexane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL2338690 | 1.00 | SMN1; SMN2 (0.69) | — | |
| Hexane SCHEMBL3504297 | 1.00 | SMN1; SMN2 (0.69) | — | |
| Hexane SCHEMBL378683 | 1.00 | SMN1; SMN2 (0.69) | — | |
| Hexane SCHEMBL378546 | 1.00 | SMN1; SMN2 (0.69) | — | |
| Hexane SCHEMBL18921395 | 1.00 | SMN1; SMN2 (0.69) | — | |
| Hexane SCHEMBL18920351 | 1.00 | SMN1; SMN2 (0.69) | — | |
| Hexane SCHEMBL7802385 | 1.00 | SMN1; SMN2 (0.69) | — | |
| Hexane SCHEMBL3826930 | 1.00 | SMN1; SMN2 (0.69) | — | |
| Hexane SCHEMBL5014044 | 1.00 | SMN1; SMN2 (0.69) | — | |
| Hexane SCHEMBL5012800 | 1.00 | SMN1; SMN2 (0.69) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4670 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119735822-A | Alkyl polyglucoside material with high-temperature stability and preparation method thereof | 武汉雪隆科技有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-115572328-B | Preparation method of medical grade III type collagen and III type collagen | 胶原蛋白(武汉)生物科技有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-115785146-B | Method for preparing glycerophosphorylcholine by alkaline method | 黑龙江八一农垦大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119640315-A | Self-assembled alpha-cobalt hydroxide/manganese oxide composite electrocatalytic oxygen evolution material and preparation method and application thereof | 山东建筑大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119374348-A | System and method for preparing carbon source raw materials of microbial culture medium | 青岛科瑞培养基有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-222342004-U | Device for separating ethanol-n-hexane-cyclohexane multi-element azeotrope by double-side-line extractive distillation | 汇智工程科技股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-222342013-U | Device for separating ethanol-n-hexane-cyclohexane multi-element azeotrope | 汇智工程科技股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-118931226-B | High-content red azo lake pigment pre-formulation and preparation method thereof | 蓬莱新光颜料化工有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-118931226-A | High-content red azo lake pigment pre-formulation and preparation method thereof | 蓬莱新光颜料化工有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118459347-A | Aryldihydronaphthalene lignans, preparation method and application thereof | 中国科学院新疆理化技术研究所 | 2024-08-09 | — | — | CN | claimed |
| EP-0240562-A4 | COMPOSITIONS CONTAINING LIPID MOLECULES WITH ENHANCED ANGIOGENIC ACTIVITY. | ANGIO MEDICAL CORP (US) | 1988-05-10 | — | — | EP | claimed |
| EP-0253022-A1 | Method for treatment of angina and myocardial infarctions with omental lipids | TRUSTEES OF BOSTON UNIVERSITY (US) | 1988-01-20 | — | — | EP | claimed |
| US-4714571-A | Process for purification of phospholipids | THE LIPOSOME COMPANY, INC. (US) | 1987-12-22 | — | — | US | claimed |
| EP-0240562-A1 | COMPOSITIONS CONTAINING LIPID MOLECULES WITH ENHANCED ANGIOGENIC ACTIVITY | Angio-Medical Corporation (US) | 1987-10-14 | — | — | EP | claimed |
| EP-0237644-A2 | Lipids from omentum and methods for cosmetic use | TRUSTEES OF BOSTON UNIVERSITY (US) | 1987-09-23 | — | — | EP | claimed |
| WO-1987003811-A1 | METHOD FOR TREATMENT OF ANGINA AND MYOCARDIAL INFARCTIONS WITH OMENTAL LIPIDS | ANGIO-MEDICAL CORPORATION (US) | 1987-07-02 | — | — | WO | claimed |
| WO-1987003804-A2 | LIPIDS FROM OMENTUM AND METHODS FOR COSMETIC USE | ANGIO-MEDICAL CORPORATION (US) | 1987-07-02 | — | — | WO | claimed |
| WO-1987001939-A1 | COMPOSITIONS CONTAINING LIPID MOLECULES WITH ENHANCED ANGIOGENIC ACTIVITY | ANGIO-MEDICAL CORPORATION (US) | 1987-04-09 | — | — | WO | claimed |
| EP-0181568-A2 | Anti-inflammatory/anti-allergic compounds | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1986-05-21 | — | — | EP | claimed |
| US-4113742-A | Process for the preparation of alpha-pyrones | UNION CHIMIQUE CONTINENTALE-U.C.C. (FR) | 1978-09-12 | — | — | US | claimed |